19.06.2013 - The University of Southern Denmark will host a new centre dedicated to genomics, proteomics and lipidomics analysis and biological network analysis.
The research infrastructure, which gained an €8m funding form the Villum Foundation, will be located at the Center for Bioanalytical Sciences of the university. "The grant is a huge boost to our interdisciplinary research programs in the biological sciences, " said Ole Jensen, who will head the new centre. "It provides us with new equipment to investigate complex biological systems, from individual biomolecules all the way to genomes, proteomes and metabolomes and systems-wide studies."
The centre will incorporate instrumentation for genomics, proteomics and lipidomics studies, and equipment and computers for detailed analysis of biomolecular structures, interactions and networks. "Integration of experimental and computational approaches is essential in modern biological research and this infrastructure grant provides us with a very strong platform for data storage, data integration and computational modelling of biomolecules and cellular networks, to the benefit of SDU researchers and their collaborators", said Jensen.
The University of Southern Denmark is already an established excellence centre for expression proteomics, pushed by funding of Denmark's government in the past.
27.07.2016 In view of the Brexit, research academies across Britain are calling for a “bold commitment” from the government. The Royal Society President urges the UK government to underwrite the research of British scientists applying for EU funding.
20.07.2016 Belgian molecular diagnostics company Biocartis Group NV has raised €55m and will use the funds mainly to expand manufacturing capacities for its PCR-based molecular diagnostics system Idylla.
19.07.2016 It is Europe’s first gene therapy company to float on Euronext: Gensight raised €40m in its IPO. And it is not the only French company that has taken the leap in an uncertain market climate – Alzheimer’s expert Pharnext also went public.
18.07.2016 When NASA blasted off to the International Space Station on Monday morning, it had UK tech on board. A miniature DNA sequencer from Oxford Nanopore will be used to keep an eye on the ISS atmosphere – and may even analyse alien DNA one day.
13.07.2016 Cell Medica has acquired Swiss antibody specialist Delenex Therapeutics. The deal nets the British cellular therapeutics developer Delenex’ proprietory antibody fragment platform Pentrabody.
12.07.2016 Vienna-based vaccine specialist Themis Bioscience GmbH has secured broad access to a promising virus vaccine vector tech by extending its license agreement with French Institut Pasteur. Its goal: to develop a Zika vaccine.
07.07.2016 Californian biopharma Medivation has agreed to confidential negotiations with its suitors, in particular the French pharmaceutical company Sanofi, which aggressively has buffeted the cancer therapy specialist for months.
06.07.2016 The European Commission started an investigation into Illumina’s and Sequenom’s 2014 patent agreement, UK-competitor Premaitha Health said. The two US companies had agreed to pool their Noninvasive Prenatal Testing IP.
04.07.2016 Cinfa Biotech is shuffling for position on the lucrative biosimilar market. The Spanish-German company has published positive results in a study for a pegfilgrastim copycat with 172 healthy volunteers in Germany.
JANUS® G3 Automation Workstations deliver real-time and future adaptability in throughput, capacity, and dynamic volume range from 0.5 μl to 5000 μl for consistent and reproducible sample preparation more